Multifunctional Antibody Platform to Improve Treatment Outcomes
Designing and developing therapeutics with superior properties for patients living with autoimmune and inflammatory diseases as well as cancer.
Designing and developing therapeutics with superior properties for patients living with autoimmune and inflammatory diseases as well as cancer.
Hinge Bio’s GEM-DIMER™ platform was developed to create the best-in-class medicines against known and novel targets.
Our HB2198 Program is being developed in the treatment of Lupus and B cell-mediated autoimmune diseases.
Hinge Bio is led by a highly experienced team that has delivered numerous platform and drug development successes.